anti-angiogenic compound (University of South Carolina)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameanti-angiogenic compound (University of South Carolina)
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsAngiogenesis disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of South Carolina
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorder

Other Information

ATC CodeN/A
Related LinksN/A